An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicity

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 2.
Figure 2.

Metabolomic and pharmacokinetic analyses. (A) The abundance of 400 individual metabolite peaks in liver tissue obtained from four strains at 0, 3, and 6 h after APAP exposure was quantitatively analyzed by 2D NMR. At 3 h, the abundance of GSH, alanine, lactate, and betaine exhibited a unique pattern in the resistant SJL/J mice, which differed from that in the three sensitive strains (DBA/2J, C57BL/6J, and SM/J). Each bar represents the average ± SD (N = 3). (B) The amount of acetaminophen (APAP) and its metabolites in bile obtained from SJL/J or B10.D2 mice at 1 and 2 h after 300 mg/kg i.p. APAP was measured by LC/MS/MS analysis. Each bar represents the average ± SE (N = 4–5) at the indicated time points, and asterisks (*) denote significant differences (P < 0.05) between two strains. Of note, there were no significant differences in APAP or any APAP-metabolite concentrations in bile at 1 h; but there were significant differences in the concentration of several metabolites at 2 h after drug exposure. At that time, B10.D2 mice had fourfold lower APAP-GSH concentration than SJL/J mice, while there was a compensatory approximately fivefold increase in the concentration of the APAP-cysteine conjugate in B10.D2 mice relative to that in SJL/J mice. CYS, cysteine; GLU, glucoronate; NAC, N-acetylcysteine; and SUL, sulfate.

This Article

  1. Genome Res. 20: 28-35

Preprint Server